Search

Displaying results 8061 - 8070 of 8194 in total

Drug
Naftopidil
go.drugbank.com/drugs/DB12092
Investigational
Naftopidil has been investigated for the treatment of Disorder of Urinary Stent.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
Vinpocetine
go.drugbank.com/drugs/DB12131
Investigational
Vinpocetine has been investigated for the treatment of Epilepsy.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
BMS-275183
go.drugbank.com/drugs/DB12144
Investigational
BMS-275183 has been used in trials studying the treatment of Tumors and Non-small Cell Lung Cancer.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
Landiolol
go.drugbank.com/drugs/DB12212
ApprovedInvestigational
Landiolol is a rapid-acting beta (β)-1 adrenergic receptor blocker that blocks the positive chronotropic effect of the beta-1 selective agonist norepinephrine. It works to reduce the heart rate, myocardial contractility, and conduction v...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 Inhibitors
Drug
MK-0777
go.drugbank.com/drugs/DB12238
Investigational
MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized Anxiety Disorder.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
Benzbromarone
go.drugbank.com/drugs/DB12319
ApprovedWithdrawn
Benzbromarone has been used in trials studying the basic science and treatment of Heart Failure, Hyperuricemia, Chronic Kidney Disease, Abnormal Renal Function, and Gout and Asymptomatic Hyperuricemia.
Categories: Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors
Drug
Indirubin
go.drugbank.com/drugs/DB12379
Investigational
Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment).
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A1 Substrates
Drug
Lisofylline
go.drugbank.com/drugs/DB12406
Investigational
Lisofylline has been investigated for the treatment of Type 1 Diabetes Mellitus.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
Drug
Omadacycline
go.drugbank.com/drugs/DB12455
ApprovedInvestigational
Omadacycline has been used in trials studying the treatment of Bacterial Pneumonia, Bacterial Infections, Community-Acquired Infections, and Skin Structures and Soft Tissue Infections. Omadacycline represents a significant advance over t...
Categories: P-glycoprotein substrates
Drug
Lucinactant
go.drugbank.com/drugs/DB04897
Approved
It contains sinapultide, a novel, hydrophobic, 21-amino acid peptide (leucine and lysine repeating units, KL4 peptide) designed to mimic human surfactant protein-B (SB-P).